Hortobagyi GN - Search Results

1

Definition of PKC-α, CDK6, and MET as therapeutic targets in triple-negative breast cancer.

Hsu YH, Yao J, Chan LC, Wu TJ, Hsu JL, Fang YF, Wei Y, Wu Y, Huang WC, Liu CL, Chang YC, Wang MY, Li CW, Shen J, Chen MK, Sahin AA, Sood A, Mills GB, Yu D, Hortobagyi GN, Hung MC. Hsu YH, et al. Among authors: hortobagyi gn. Cancer Res. 2014 Sep 1;74(17):4822-35. doi: 10.1158/0008-5472.CAN-14-0584. Epub 2014 Jun 26. Cancer Res. 2014. PMID: 24970481 Free PMC article.

2

Overview of new treatments for breast cancer.

Hortobagyi GN. Hortobagyi GN. Breast Cancer Res Treat. 1992;21(1):3-13. doi: 10.1007/BF01811959. Breast Cancer Res Treat. 1992. PMID: 1356516

3

Bone metastasis in breast cancer.

Theriault RL, Hortobagyi GN. Theriault RL, et al. Among authors: hortobagyi gn. Anticancer Drugs. 1992 Oct;3(5):455-62. doi: 10.1097/00001813-199210000-00002. Anticancer Drugs. 1992. PMID: 1450438 Review.

4

Feasibility of breast-conservation surgery after induction chemotherapy for locally advanced breast carcinoma.

Singletary SE, McNeese MD, Hortobagyi GN. Singletary SE, et al. Among authors: hortobagyi gn. Cancer. 1992 Jun 1;69(11):2849-52. doi: 10.1002/1097-0142(19920601)69:11<2849::aid-cncr2820691134>3.0.co;2-p. Cancer. 1992. PMID: 1571916

5

Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosis.

Sahin AA, Ro J, Ro JY, Blick MB, el-Naggar AK, Ordonez NG, Fritsche HA, Smith TL, Hortobagyi GN, Ayala AG. Sahin AA, et al. Among authors: hortobagyi gn. Cancer. 1991 Aug 1;68(3):549-57. doi: 10.1002/1097-0142(19910801)68:3<549::aid-cncr2820680318>3.0.co;2-j. Cancer. 1991. PMID: 1648433

6

Lack of correlation between histologic findings and response to chemotherapy in metastatic breast cancer.

Ziegler LD, Connelly JH, Frye D, Smith TL, Hortobagyi GN. Ziegler LD, et al. Among authors: hortobagyi gn. Cancer. 1991 Aug 1;68(3):628-33. doi: 10.1002/1097-0142(19910801)68:3<628::aid-cncr2820680331>3.0.co;2-3. Cancer. 1991. PMID: 1648436

7

Clinical course of patients with breast cancer with ten or more positive nodes who were treated with doxorubicin-containing adjuvant therapy.

Buzdar AU, Kau SW, Hortobagyi GN, Ames FC, Holmes FA, Fraschini G, Hug V, Theriault RL, McNeese MD, Singletary SE. Buzdar AU, et al. Among authors: hortobagyi gn. Cancer. 1992 Jan 15;69(2):448-52. doi: 10.1002/1097-0142(19920115)69:2<448::aid-cncr2820690229>3.0.co;2-k. Cancer. 1992. PMID: 1728373

8

A randomized trial of two dosage schedules of mitomycin C in advanced breast carcinoma.

Walters RS, Frye D, Buzdar AU, Holmes FA, Hortobagyi GN. Walters RS, et al. Among authors: hortobagyi gn. Cancer. 1992 Jan 15;69(2):476-81. doi: 10.1002/1097-0142(19920115)69:2<476::aid-cncr2820690234>3.0.co;2-0. Cancer. 1992. PMID: 1728377 Clinical Trial.

9

Phase II evaluation of interferon added to tamoxifen in the treatment of metastatic breast cancer.

Macheledt JE, Buzdar AU, Hortobagyi GN, Frye DK, Gutterman JU, Holmes FA. Macheledt JE, et al. Among authors: hortobagyi gn. Breast Cancer Res Treat. 1991 Aug;18(3):165-70. doi: 10.1007/BF01990032. Breast Cancer Res Treat. 1991. PMID: 1756259 Clinical Trial.

10

Is chemotherapy effective in reducing the local failure rate in patients with operable breast cancer?

Buzdar AU, McNeese MD, Hortobagyi GN, Smith TL, Kau S, Fraschini G, Hug V, Ellerbroek N, Holmes FA, Ames F, et al. Buzdar AU, et al. Among authors: hortobagyi gn. Cancer. 1990 Feb 1;65(3):394-9. doi: 10.1002/1097-0142(19900201)65:3<394::aid-cncr2820650303>3.0.co;2-2. Cancer. 1990. PMID: 2297630

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,108 results

Search Page

Filters